Yu‐Shih Lin

720 total citations · 1 hit paper
21 papers, 576 citations indexed

About

Yu‐Shih Lin is a scholar working on Molecular Biology, Complementary and alternative medicine and Cancer Research. According to data from OpenAlex, Yu‐Shih Lin has authored 21 papers receiving a total of 576 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Complementary and alternative medicine and 5 papers in Cancer Research. Recurrent topics in Yu‐Shih Lin's work include Traditional Chinese Medicine Analysis (5 papers), Computational Drug Discovery Methods (4 papers) and Cancer-related molecular mechanisms research (4 papers). Yu‐Shih Lin is often cited by papers focused on Traditional Chinese Medicine Analysis (5 papers), Computational Drug Discovery Methods (4 papers) and Cancer-related molecular mechanisms research (4 papers). Yu‐Shih Lin collaborates with scholars based in Taiwan and United States. Yu‐Shih Lin's co-authors include Ching‐Yuan Wu, Yao‐Hsu Yang, Yu‐Ching Cheng, Li‐Hsin Shu, Jrhau Lung, Wen‐Huang Peng, Geng‐He Chang, Cheng‐Ming Hsu, Ming‐Shao Tsai and Jong‐Yuh Cherng and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Nutrients.

In The Last Decade

Yu‐Shih Lin

21 papers receiving 569 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase

2020 225 citations Jrhau Lung, Yu‐Shih Lin et al. Journal of Medical Virology profile →

Peers

Countries citing papers authored by Yu‐Shih Lin

Since Specialization

Citations

This map shows the geographic impact of Yu‐Shih Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Shih Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Shih Lin more than expected).

Fields of papers citing papers by Yu‐Shih Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Shih Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Shih Lin. The network helps show where Yu‐Shih Lin may publish in the future.

Co-authorship network of co-authors of Yu‐Shih Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Shih Lin. A scholar is included among the top collaborators of Yu‐Shih Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Shih Lin. Yu‐Shih Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antrodia cinnamomea Formula Suppresses Prostate Cancer Progression via Immune Modulation and PD-1/PD-L1 Pathway Inhibition 2025 ·International Journal of Molecular Sciences ·Ming-Yen Tsai, (unknown), Li‐Hsin Shu, (unknown), (unknown), Yu‐Shih Lin, Hsiao‐Yu Yang, (unknown), (unknown), (unknown), Ching-Yuan Wu	2
2	The effect and mechanism of astragalus polysaccharides on T cells and macrophages in inhibiting prostate cancer 2024 ·Biomedical Journal ·Ching‐Yuan Wu, Yao‐Hsu Yang, Yu‐Shih Lin, Li‐Hsin Shu, (unknown), Chung‐Kuang Lu, (unknown), (unknown)	3
3	Astragalus Polysaccharides and Metformin May Have Synergistic Effects on the Apoptosis and Ferroptosis of Lung Adenocarcinoma A549 Cells 2024 ·Current Issues in Molecular Biology ·(unknown), (unknown), (unknown), (unknown), (unknown), Cheng‐Ming Hsu, Yu‐Shih Lin, (unknown), Ching-Yuan Wu	2
4	The Inhibiting Effect of GB-2, (+)-Catechin, Theaflavin, and Theaflavin 3-Gallate on Interaction between ACE2 and SARS-CoV-2 EG.5.1 and HV.1 Variants 2024 ·International Journal of Molecular Sciences ·Chung‐Kuang Lu, Jrhau Lung, Li‐Hsin Shu, (unknown), (unknown), Yu‐Shih Lin, Yao‐Hsu Yang, (unknown), Ching‐Yuan Wu	3
5	Inhibition of orthotopic castration-resistant prostate cancer growth and metastasis in mice by JC VLPs carrying a suicide gene driven by the PSA promoter 2023 ·Cancer Gene Therapy ·(unknown), (unknown), Yu‐Shih Lin, Meilin Wang, Pei‐Lain Chen, Deching Chang, Cheng‐Huang Shen, Chiung‐Yao Fang	1
6	Induction of ferroptosis and apoptosis in endometrial cancer cells by dihydroisotanshinone I 2023 ·Heliyon ·Ching‐Yuan Wu, Yao‐Hsu Yang, Yu‐Shih Lin, Li‐Hsin Shu, (unknown), (unknown), (unknown)	4
7	The anti-SARS-CoV-2 effect and mechanism of Chiehyuan herbal oral protection solution 2023 ·Heliyon ·Ching‐Yuan Wu, Yao‐Hsu Yang, Yu‐Shih Lin, Li‐Hsin Shu, Yu‐Ching Cheng, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Geng‐He Chang, Cheng‐Ming Hsu, (unknown), (unknown), (unknown), (unknown), Ming‐Shao Tsai	2
8	Nasal irrigation with licorice extract (Glycyrrhiza glabra) in treating nasal polyps by reducing fibroblast differentiation and extracellular matrix production in TGF-β1-stimulated nasal polyp-derived fibroblasts by inhibiting the MAPK/ERK-1/2 pathway – an in vitro and in clinic study 2022 ·BMC Complementary Medicine and Therapies ·Geng‐He Chang, (unknown), Yu‐Ching Cheng, (unknown), Ching‐Yuan Wu, Yao‐Hsu Yang, Yu‐Shih Lin, Cheng‐Ming Hsu, Ming‐Shao Tsai, Yao‐Te Tsai, Pey‐Jium Chang	5
9	Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations 2022 ·Biomedicine & Pharmacotherapy ·Ming‐Shao Tsai, (unknown), Yao‐Hsu Yang, Yu‐Shih Lin, Geng‐He Chang, Cheng‐Ming Hsu, (unknown), Li‐Hsin Shu, Yu‐Ching Cheng, (unknown), (unknown), (unknown), (unknown), Ching‐Yuan Wu	9
10	Nasal irrigation with Glycyrrhiza glabra extract for treatment of allergic rhinitis – A study of in vitro, in vivo and clinical trial 2021 ·Journal of Ethnopharmacology ·Geng‐He Chang, Yu‐Shih Lin, (unknown), Yu‐Ching Cheng, (unknown), Ming‐Shao Tsai, Yao‐Te Tsai, Cheng‐Ming Hsu, Pey‐Jium Chang, Chung‐Sheng Shi, Yao‐Hsu Yang, Ching‐Yuan Wu	19
11	GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2 2021 ·Biomedicine & Pharmacotherapy ·Ming‐Shao Tsai, Yao‐Hsu Yang, Yu‐Shih Lin, Geng‐He Chang, Cheng‐Ming Hsu, (unknown), Li‐Hsin Shu, Yu‐Ching Cheng, (unknown), (unknown), (unknown), (unknown), Ching‐Yuan Wu	10
12	Dihydroisotanshinone I induced ferroptosis and apoptosis of lung cancer cells 2021 ·Biomedicine & Pharmacotherapy ·Ching‐Yuan Wu, Yao‐Hsu Yang, Yu‐Shih Lin, Geng‐He Chang, Ming‐Shao Tsai, Cheng‐Ming Hsu, (unknown), Li‐Hsin Shu, Yu‐Ching Cheng, (unknown)	52
13	The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase breakdown → 2020 ·Journal of Medical Virology ·Jrhau Lung, Yu‐Shih Lin, Yao‐Hsu Yang, (unknown), Li‐Hsin Shu, Yu‐Ching Cheng, (unknown), Ching‐Yuan Wu	225
14	Anxiolytic effect of an extract of Salvia miltiorrhiza Bunge (Danshen) in mice 2020 ·Journal of Ethnopharmacology ·Yu‐Shih Lin, Wen‐Huang Peng, Mei‐Fen Shih, Jong‐Yuh Cherng	37
15	GB-2 inhibits ACE2 and TMPRSS2 expression: In vivo and in vitro studies 2020 ·Biomedicine & Pharmacotherapy ·Ching‐Yuan Wu, Yu‐Shih Lin, Yao‐Hsu Yang, Li‐Hsin Shu, Yu‐Ching Cheng, (unknown)	28
16	Danshen Improves Survival of Patients With Breast Cancer and Dihydroisotanshinone I Induces Ferroptosis and Apoptosis of Breast Cancer Cells 2019 ·Frontiers in Pharmacology ·Yu‐Shih Lin, (unknown), Ching‐Yuan Wu, (unknown), Yao‐Hsu Yang, (unknown), Feng‐Che Kuan, (unknown), Geng‐He Chang, Ming‐Shao Tsai, Cheng‐Ming Hsu, (unknown), (unknown), (unknown), Li‐Hsin Shu, Yu‐Ching Cheng, (unknown), (unknown), (unknown), Deching Chang	94
17	Antrodia cinnamomea extract inhibits the proliferation of tamoxifen-resistant breast cancer cells through apoptosis and skp2/microRNAs pathway 2018 ·BMC Complementary and Alternative Medicine ·Yu‐Shih Lin, (unknown), Yao‐Hsu Yang, Chun‐Liang Lin, Feng‐Che Kuan, (unknown), Geng‐He Chang, Ming‐Shao Tsai, Cheng‐Ming Hsu, (unknown), (unknown), (unknown), Li‐Hsin Shu, Yu‐Ching Cheng, (unknown), Kuan‐Der Lee, Deching Chang, Ching‐Yuan Wu	32
18	The Hepatoprotective Effects Of Coptisine On Carbon Tetrachloride Induced Acute Liver Damage In Mice 2018 ·Proceedings for Annual Meeting of The Japanese Pharmacological Society ·(unknown), (unknown), Yu‐Shih Lin, (unknown), Jen-Chieh Tsai, Wen‐Huang Peng, (unknown)	1
19	Toward Discovering New Anti-Cancer Agents Targeting Topoisomerase IIα: A Facile Screening Strategy Adaptable to High Throughput Platform 2014 ·PLoS ONE ·Yu‐Shih Lin, Wan‐Chen Huang, (unknown), Tao‐shih Hsieh	5
20	Cortex Moutan Inhibits Bladder Cancer Cell Proliferation and Expression of Angiogenic Factors 2014 ·Pharmacology &amp Pharmacy ·(unknown), Cheng‐Huang Shen, Su‐Yin Chiang, (unknown), Yu‐Shih Lin, Cheng‐Da Hsu	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact